Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial [CONgenitale Cmv: Effectiviteit van antivirale therapie in een geRandomiseerde gecontroleerd Trial]

Trial Profile

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial [CONgenitale Cmv: Effectiviteit van antivirale therapie in een geRandomiseerde gecontroleerd Trial]

Discontinued
Phase of Trial: Phase III

Latest Information Update: 24 Jun 2015

At a glance

  • Drugs Valganciclovir (Primary)
  • Indications Cytomegalovirus infections; Sensorineural hearing loss
  • Focus Therapeutic Use
  • Acronyms CONCERT
  • Most Recent Events

    • 24 Jun 2015 Last checked against ClinicalTrials.gov record.
    • 04 Nov 2013 Planned end date changed from 1 Jun 2015 to 1 Jun 2014 as reported by ClinicalTrials.gov.
    • 04 Nov 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top